India Plans Tighter Enforcement At State Level To Counter Spread Of Spurious Drugs
This article was originally published in PharmAsia News
Executive Summary
India plans to step-up enforcement as some generic drug manufacturers continue to take shortcuts, ignoring the prospect of harsh penalties under a law passed two years ago.
You may also be interested in...
Track And Trace Systems Under Negotiations In India To Protect Industry Reputation
MUMBAI - Pharmaceutical goods exported from India will be subject to intense scrutiny as government agencies kick off negotiations with industry stakeholders to adopt suitable tracing and tracking technologies to establish the genuineness of drugs manufactured in India
Tighter Legal Provisions Will Deter Spurious Drugs In India But May Be Misused Too, Say Legal Experts
MUMBAI - After years of delay, the Indian government has finally tightened the legal provisions to punish companies charged with manufacturing of adulterated or spurious drugs, but according to legal experts certain ambiguities in the amendments have raised doubts of misuse of the law
Indian Investors Turn Cautious On Compliance Concerns
A rising number of enforcement actions by major drug regulators like the U.S. FDA is slowly making investors cautious about the longer term repercussions on earnings of Indian drug makers.